Purisys Llc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is CANNABIDIOL DRUG SUBSTANCE, with a corresponding US DMF Number 33223.
Remarkably, this DMF maintains an Active status since its submission on February 22, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 15, 2022, and payment made on March 10, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II